Masamichi Sugimoto

2.1k citations
45 papers · 1.7k indexed · h-index 19
Topics
Monoclonal and Polyclonal Antibodies Research (11 papers)Glycosylation and Glycoproteins Research (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)

In The Last Decade

Masamichi Sugimoto

44 papers receiving 1.6k citations

Peers

Masamichi Sugimoto
Comparison fields: 5 of 107
  • Molecular Biology 526
  • Oncology 506
  • Rheumatology 465
  • Immunology 365
  • Radiology, Nuclear Medicine and Imaging 200
Replace Dirk Pohlers with:
Dirk Pohlers Germany
Tina Manon‐Jensen Denmark
Maogen Chen China
Doru T Alexandrescu United States
Qiong Fu China
Koji Yoshida Japan
Ji Eun Kim South Korea
Daisuke Goto Japan
K Obata Japan
Giuseppe Pannone Italy
Masamichi Sugimoto relative to Dirk Pohlers Germany Dirk Pohlers's profile →
Citations per field
00.5×1.5×2.2×
Dirk Pohlers · 1×
Citations per year

Countries citing papers authored by Masamichi Sugimoto

Since Specialization
Citations

This map shows the geographic impact of Masamichi Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masamichi Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masamichi Sugimoto more than expected).

Fields of papers citing papers by Masamichi Sugimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masamichi Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masamichi Sugimoto. The network helps show where Masamichi Sugimoto may publish in the future.

Co-authorship network of co-authors of Masamichi Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masamichi Sugimoto. A scholar is included among the top collaborators of Masamichi Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masamichi Sugimoto. Masamichi Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 12
3 6
4 2
5 13
6 35
7 25
8 6
9 14
10 22
11 18
12 18
13 91
14 127
15 258
16 129
17 8
18 323
19 27
20 2

About Masamichi Sugimoto

Masamichi Sugimoto is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Rheumatology (465 citations), Urology (119 citations) and Oncology (506 citations). Masamichi Sugimoto has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Kazuyuki Yoshizaki, Norihiro Nishimoto, Keisuke Hagihara, Hideko Nakahara, Tadamitsu Kishimoto, Jian Song, Ernst B. Hunziker, Shigeto Kawai, Yoshiyuki Ohsugi and Yoshihiro Matsumoto. Their work appears in journals such as The Journal of Immunology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026